Trinity Biotech (TRIB) Long-Term Investments (2009 - 2025)

Trinity Biotech has disclosed Long-Term Investments across 9 years of filings, most recently posting $249000.0 for Q4 2025.

• Long-Term Investments for Q4 2025 came in at $249000.0, down 89.86% year-over-year; the trailing twelve-month figure through Dec 2025 was $249000.0 (down 89.86% YoY), and the FY2025 annual result was $249000.0, down 89.86% from the prior year.
• Long-Term Investments came in at $249000.0 for Q4 2025 at Trinity Biotech, down from $2.8 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $2.8 million in Q2 2025 to a low of $128000.0 in Q4 2022.
• The 4-year median for Long-Term Investments is $249000.0 (2025), against an average of $1.2 million.
• Across the five-year window, Long-Term Investments soared 1279.21% in 2024 and tumbled 89.86% in 2025, its largest moves.
• Trinity Biotech's Long-Term Investments stood at $128000.0 in 2022, then surged by 39.06% to $178000.0 in 2023, then jumped by 1279.21% to $2.5 million in 2024, then sank by 89.86% to $249000.0 in 2025.
• The last three Long-Term Investments figures came in at $249000.0 (Q4 2025), $2.8 million (Q2 2025), and $2.5 million (Q4 2024), per Business Quant data.